Anlotinib for Hepatocellular Carcinoma
NCT04954521
·
clinicaltrials.gov ↗
UNKNOWN
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Liver Neoplasms
Interventions
DRUG:
Anlotinib
Sponsor
People's Hospital of Guangxi Zhuang Autonomous Region